Detection Times for Performance Enhancing Substances

PALMETTO, FLA. — Equine Sports Council (ESC) uses a common-sense clinical efficacy approach when sanctioning the use of controlled medications, allowing therapeutic regimens while restricting performance-enhancing substances. Our show horse population averages 12 years of age (equivalent to a 55-year-old human) and deserves to be comfortable while performing their jobs. What are not allowed are substances (or combinations thereof) considered performance-enhancing, such as sedatives, tranquilizers, stimulants, and certain painkillers. [1, 2, 3, 4, 5]

At times, it may become medically necessary to treat a horse at an ESC show with a sedative to address an injury or to safely haul them into a competition. In these situations, ESC publishes withdrawal times to ensure the clinical efficacy of the medication has cleared the horse’s system before competition. When medications are detected during drug testing via blood sampling, the concentration levels provided by the lab indicate how much was in the horse’s system and how strong it was. This translates to how effective the medication was at the time of competition, which is exactly what ESC drug testing targets. [1, 2]

Once a medication has been metabolized and is no longer effective, it is typically no longer present in the blood. However, traces or identifiers (metabolites or the parent drug) of the medication may continue to be present in the horse’s urine for days or weeks, even though the drug is no longer effective. Labs also have the ability to perform drug testing by sampling the mane or tail, configuring their scans to detect drug use up to a year after a single administration. ESC drug testing does not target historical medication use outside of the show ring. [1]

The ESC Controlled Medication database provides efficacy and detection values, which may be needed when horses compete under different sanctioning bodies. For example, under other organizations, the bronchodilator Clenbuterol is strictly prohibited and may be detectable for up to a year if hair sample drug testing is performed. [1]

At a high level, here are some of the most commonly prescribed medications and their continued detection times in urine, despite no longer having an active efficacy presence in the blood:

The following therapeutic substances, sedatives, and local anesthetics exhibit a prolonged detection window in equine urine compared to blood plasma: [1, 2]

• Medetomidine: The parent drug becomes undetectable in plasma within 4 hours, but its primary metabolites (such as hydroxymedetomidine) remain highly quantifiable in urine for up to 72 hours. [1]

• Acepromazine: Traces of its highly stable urinary metabolite (HEPS) can remain detectable in urine for up to 100 hours (or up to 30 days after repeated oral dosing), whereas plasma clearance typically drops below regulatory limits much faster. [1, 2, 3]

• Procaine: When administered (often as part of Procaine Penicillin G), the local anesthetic procaine is rapidly cleared from plasma (often within 24 hours) but can concentrate and be excreted in urine for 78 to 120 hours after a single dose. [1, 2, 3]

• Diazepam: Following intravenous administration, the parent drug quickly clears from plasma (around 24 hours), but its glucuronide conjugate metabolites can be captured in urine for up to 58 hours. [1]

• Albuterol: Often given as a bronchodilator, it clears relatively quickly from the bloodstream but accumulates heavily in urine, requiring a longer regulatory withdrawal period due to a 1 ng/mL urinary threshold. [1, 2, 3]

• Cocaine / Benzoylecgonine: While a prohibited substance rather than a routine therapeutic, cocaine is rapidly metabolized into benzoylecgonine. Its concentration in equine urine can approach 2,000 times higher than concurrent levels in plasma. [1]

Most NSAIDs are highly bound to plasma proteins (>95%), and while they clear the active bloodstream relatively quickly, they are excreted and concentrated heavily in equine urine. [1]

• Phenylbutazone (“Bute”): Its plasma half-life is roughly 4 to 8 hours, dropping below regulatory plasma thresholds quickly. However, the parent drug and its active metabolites (oxyphenbutazone and γ-hydroxyphenylbutazone) can remain highly detectable in urine past the 24-hour mark. [1]
  
• Flunixin Meglumine (Banamine): Clears plasma rapidly, but it accumulates in the urine. Because of this dual-matrix reality, regulatory bodies enforce a strict 1.8-day (43-hour) or greater withdrawal period to clear urinary detection limits depending on the jurisdiction.
  
• Ibuprofen & Ketoprofen: While ketoprofen has a remarkably short plasma half-life (~1 hour), sensitive testing (like GC-MS/MS) easily picks up unchanged parent drug and conjugated metabolites in urine for days. [1, 2]
  
• Salicylic Acid (Aspirin): Regulators account for this matrix difference by adjusting thresholds. For example, international standards allow a much higher regulatory limit in urine (750 µg/mL) compared to plasma (6.5 µg/mL) to prevent a false positive from natural dietary intake while tracking actual administration. [1]

2. Corticosteroids

The detection gap between plasma and urine is even wider for corticosteroids, particularly long-acting, esterified formulations injected directly into joints (intra-articular). [1, 2]

• Triamcinolone Acetonide (Vetalog): Similar to methylprednisolone, it is rapidly cleared from circulating plasma but undergoes prolonged excretion into the urine. Regulatory systems require a mandatory 7-day to 14-day clearance window primarily because urine testing can catch trace amounts long after plasma levels look completely clean. [1]

• Methylprednisolone Acetate (Depo-Medrol): This is one of the most notorious examples of a prolonged detection window. When injected intra-articularly, it can be detected in plasma for up to 13 days, but it continues to leach out and remains highly detectable in urine for up to 21 days or longer. (Notably, it can linger in the joint’s synovial fluid for up to 70 days). [1, 2]

• Dexamethasone: When given intravenously or intramuscularly, dexamethasone drops below plasma detection limits quite rapidly (often within 24–48 hours). However, its major unconjugated metabolites concentrate in urine, extending the urinary detection window out. [1, 2, 3, 4]